einstein em case presentation
DESCRIPTION
Einstein EM Case Presentation. - Kevin Carey 7/ 20. CC: 67yo male BIBEMS after a social worker visited him and reported he was acting lethargic - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/1.jpg)
- Kevin Carey 7/20
*Einstein EM Case Presentation
![Page 2: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/2.jpg)
*Case HistoryCC: 67yo male BIBEMS after a social worker visited him and reported he was acting lethargicHPI: - Pt speaks slowly and appears lethargic but is A&Ox3 and doesn’t understand why the social worker activated EMS. - Has been drinking beer and vodka and abusing cocaine for several days. - Reports: falling and hitting his head 2x, having abdominal pain and a single episode of chest pain. - Denies: Current chest pain, SOB, headaches, episodes of NV, weaknessPMHx:- HTN, CKD, Gout- Current Meds unknown- Soc: Denies IVDU
![Page 3: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/3.jpg)
*Case PhysicalV/S:- T: 97.2 HR: 105 BP: 79/53 RR: 15 O2: 99% on RAExam:- Gen: Lethargic, slowly answers questions. Requires redirection- Neuro: A&O x 3, No focal deficits, gait not assessed- HENT: Dry mucus membranes, PERRL, EOMI- Cards: S1/S2, No MRG, No JVD- Pulm: CTAB- Abd: Soft, Non-tender, +BS- Ext: +1 Bilateral LE Edema, (No record of DTRs)
![Page 4: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/4.jpg)
*DifferentialCards:- Cocaine induce MI- HypovolemiaMetabolic:- Electrolyte abnormality- Toxic AlcoholInfectious:- SIRS
Neuro:- SubduralPulm:- PEGI:- Pancreatitis
![Page 5: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/5.jpg)
*Labs & EKGLabs:WBC: 5.9H&H: 10.2/32.3Plts: 273Na: 141K: 8.4Cl: 114CO2: 6.9BUN: 131Crea: 21 (Baseline 1.9)Glu: 120Gap: 20.1LFTs: WNL UA: +Protein, - RBC, Nitrate LEFeNa: .5%
![Page 6: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/6.jpg)
*HyperkalemiaBrief Potassium Physiology:- Relative concentrations of intra/extracellular potassium are the major determinants of electrochemical gradients in all living cells - 98% of the body’s potassium is intracellular - Extracellular K+ tightly regulated between 3.5-5.0mEq/L- 90% is renally excretedCauses:- Most frequently seen in ESRD patients who have missed dialysis appointments and patients w/ acute renal failure. - DKA, Rhabdomyolysis (Crush/Burn injuries),Severe Acidosis
*Laboratory Hemolysis is the most common cause of an abnormal K+.
![Page 7: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/7.jpg)
*Signs & SymptomsHistory:- Weakness, muscle cramps, paresthesias, N/V/D, & palpitationsPhysical:- Paresthesias, decreased strength, absence of DTRs- Audible arrhythmias- Hyperchloremic Metabolic Acidosis- EKG changes:
- Typically occur at a plasma K > 6.5meq- Typical progression:
1) Peaked T-Waves (6.5 -7.5meq)2) Widening of the QRS (7.5 – 8.5meq)3) Loss of P Waves (7.5 – 8.5meq)4) Sine Waves / V-Fib (>10meq)5) Asystole
**EKG changes can occur in any order and at varying potassium levels**
![Page 8: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/8.jpg)
*Treating Severe HyperkalemiaCritical Care Medicine, 2008
![Page 9: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/9.jpg)
*Treatment OverviewWho/When do we treat emergently?-Hemodynamically Unstable, EKG Changes or K+ > 6.5- Suspected spike in K+: Crush injuries, tumor-lysis syndromeHow do we treat?1) Stabilization of the cardiac membrane2) Redistribute extracellular K+ into cells3) Eliminate K+ from the bodyDispo:- Admission for cardiac and electrolyte monitoring and
nephrology consult are required for moderate or severe cases-Home is only an option for mild cases where the patient is
hemodynamically stable and has close outpatient follow-up
![Page 10: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/10.jpg)
*Calcium & Cardiac Stabilization- Calcium has NO effect on Extracellular K
- Calcium Stabilizes Cardiac Myocytes by: 1) Increasing the Threshold Potential 2) Restoring contractility/Vmax 3) Increasing Ca+, increases SA/AV signal propagation
- Dosing and Duration- 1 amp of Ca Gluconate is given over 10min - Effect is theoretically immediate with EKG changes within 3 min- Lasts 30-60min
![Page 11: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/11.jpg)
*Potassium RedistributionInsulin
- Effects seen within 20 min - Decreases K by 0.6-1.0 mEq/L for 4-6 hours- Given with a bolus of D50 in patients with a glucose < 250Albuterol (Beta-Agonists)- Effects seen within 30min- Decreases K by 0.6-1.0 mEq/L for 2 hours*Albuterol and Insulin are synergistic and result in a reduction of ~1.2 - 1.5 mEq/LBicarb- Not effective in reducing extracellular K+ - Should only be used to treat an underlying metabolic acidosis
![Page 12: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/12.jpg)
*Elimination of Potassium Furosemide
- Onset in ~30min- Patients must be able to make urineKayexalate- Most common treatment- Cation exchange resin which binds K+ in the gut and releases Na+- 1-2 hours to initial onset with 12 hour fecal potassium output ~31meqHemodialysis- Most effective treatment. Can remove 25-50 meq per hour- HD the patient if the measures above are insufficient or the hyperkalemia is severe
![Page 13: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/13.jpg)
*Treatment Summary
![Page 14: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/14.jpg)
*Our PatientDx: - Acute on Chronic Kidney Injury 2/2 hypovolemia and cocaine useED Tx: - Pt received 2L NS, Calcium, Insulin, Kayexalate and a Bicarb dripOutcome:- K was reduced to 6.0 by the time he was transferred
to the floor- Pt course complicated by ATN & DTs
![Page 15: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/15.jpg)
*Hyperkalemia Take-AwaysWho do we treat emergently?
-Hemodynamically Unstable, EKG Changes, or K+ > 6.5- Suspected spike in K+: Crush injuries, tumor-lysis
syndromeWhat do we treat with?- Pneumonic: ABCDE
- A: Albuterol- B: BiCarb- C: Calcium- D: Dextrose/Insulin, Diuretics, Dialysis- E: kayExalate
![Page 16: Einstein EM Case Presentation](https://reader035.vdocuments.net/reader035/viewer/2022070422/5681658d550346895dd8590a/html5/thumbnails/16.jpg)
*ReferencesWeisberg, L. "Management of severe hyperkalemia" Critical Care Medicine 2008; 36: 3246-3251.
Parham WA, Mehdirad AA, Biermann KM, Fredman CS. Hyperkalemia revisited. Tex Heart Inst J. 2006;33:40–7.
Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38:869.
Mount, David B. Treatment and prevention of hyperkalemia. In: Up To Date, Travis, Anne. UpToDate, Waltham, MA 2012